Skip to main content

Franklin, Parlapiano, Turner & Welch, LLC

Position in NVS — Novartis AG

CIK 1707856 HOUSTON, TX

Position in NVS

as of Jun 30, 2026 · filed Jul 9, 2026
Position Value
$9,938,242
-$4,561 QoQ
Shares Held
63,414
-2.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
5.57%
of 13F equity value
Holder Rank
#175
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Franklin, Parlapiano, Turner & Welch, LLC holds $22,184,817 across 4 Drug Manufacturers - General names. NVS ranks #2 (44.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVS
Novartis AG
This page
63,414 $9,938,242

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,938,242 63,414
2026-03-31 $9,942,803 65,092
2025-12-31 $9,721,351 70,511
2025-09-30 $9,487,066 73,979
2025-06-30 $9,177,519 75,841
2025-03-31 $8,430,117 75,620
2024-12-31 $7,342,039 75,450
2024-09-30 $8,654,564 75,244
2024-06-30 $8,035,281 75,477
2024-03-31 $7,330,973 75,788
2023-12-31 $7,681,797 76,080
2023-09-30 $7,834,460 76,914
2023-06-30 $7,922,746 78,513
2023-03-31 $7,397,996 80,413
2022-12-31 $7,279,463 80,241
2022-09-30 $6,063,165 79,768
2022-06-30 $6,662,062 78,813
2022-03-31 $6,833,706 77,877
2021-12-31 $6,463,245 73,891
2021-09-30 $5,609,290 68,590
2021-06-30 $6,237,440 68,363
2021-03-31 $5,614,753 65,685
2020-12-31 $5,929,070 62,788
2020-09-30 $5,334,561 61,345
2020-06-30 $5,293,328 60,606
2020-03-31 $5,091,452 61,752